Clindamycin-2-phosphate: pharmacokinetics and clinical use
Saito, Y.; Kato, Y.; Ishikawa, K.; Tomizawa, M.; Nakayama, I.
Japanese Journal of Antibiotics 30(3): 228-233
1977
ISSN/ISBN: 0368-2781 PMID: 853580 Document Number: 114582
Document emailed within 1 workday
Related Documents
Yamazaki, M.; Tanabe, K.; Arima, Y.; Matsumoto, Y.; Kimijima, K. 1972: Action of clindamycin-2-phosphate and clindamycin-2-palmitate on the central nervous system Japanese Journal of Antibiotics 25(3): 169-174Shibata, K.; Yura, J.; Shinagawa, N.; Suzuki, K.; Suzuki, Y. 1977: Clinical application of clindamycin-2-phosphate in surgery Japanese Journal of Antibiotics 30(3): 237-241
Nakayama, I.; Iwamoto, H.; Iwai, S.; Kawabe, T.; Mizuashi, H. 1977: Clindamycin-2-phosphate: absorption, excretion metabolism, tissue levels and clinical use in surgery Japanese Journal of Antibiotics 30(4): 266-277
Tokuda, H.; Hatano, H.; Kayaba, T. 1977: Use of clindamycin-2-phosphate in ophthalmology Japanese Journal of Antibiotics 30(1): 107-110
Ohlson, J.; Dakovic, R.; Berg, M. 2019: Observational Study of Clindamycin Phosphate and Tretinoin Gel for the Treatment of Acne Journal of Drugs in Dermatology: Jdd 18(4): 328-334
Mashimo, K.; Kunii, O.; Fukaya, K.; Kimura, M.; Komatsu, T. 1977: A case of subacute bacterial endocarditis treated with clindamycin-2-phosphate Japanese Journal of Antibiotics 30(1): 23-26
Bowman, S.; Gold, M.; Nasir, A.; Vamvakias, G. 2005: Comparison of clindamycin/benzoyl peroxide, tretinoin plus clindamycin, and the combination of clindamycin/benzoyl peroxide and tretinoin plus clindamycin in the treatment of acne vulgaris: a randomized, blinded study Journal of Drugs in Dermatology: Jdd 4(5): 611-618
Gyenes, V.; Szabó, G.; Velich, N. 1998: Intra-arterial administration of Dalacin C phosphate (clindamycin) in the therapy of osteomyelitis of the jaws Fogorvosi Szemle 91(8-9): 257-260
Foley, P.T.; Bosso, J.A.; Bair, J.N.; Townsend, R.J. 1985: Compatibility of clindamycin phosphate with cefotaxime sodium or netilmicin sulfate in small-volume admixtures American Journal of Hospital Pharmacy 42(4): 839-843
Freeman, S.A.; Moon, S.D.; Spencer, J.M. 2012: Clindamycin phosphate 1.2% and tretinoin 0.025% gel for rosacea: summary of a placebo-controlled, double-blind trial Journal of Drugs in Dermatology: Jdd 11(12): 1410-1414
Perez, M.; Aspiolea, F.; De Moragas, J.M. 1987: Comparative double-blind study of topical clindamycin phosphate and oral tetracycline in the treatment of acne Medicina Cutanea Ibero-Latino-Americana 15(3): 173-177
Nahata, M.C.; Morosco, R.S.; Hipple, T.F. 1993: Stability of cimetidine hydrochloride and of clindamycin phosphate in water for injection stored in glass vials at two temperatures American Journal of Hospital Pharmacy 50(12): 2559-2561
Stoughton, R.B.; Cornell, R.C.; Gange, R.W.; Walter, J.F. 1980: Double-blind comparison of topical 1 percent clindamycin phosphate (Cleocin T) and oral tetracycline 500 mg/day in the treatment of acne vulgaris Cutis 26(4): 424-425; 429
Callender, V.D. 2012: Fitzpatrick skin types and clindamycin phosphate 1.2%/benzoyl peroxide gel: efficacy and tolerability of treatment in moderate to severe acne Journal of Drugs in Dermatology: Jdd 11(5): 643-648
Zeichner, J.A.; Wong, V.; Linkner, R.V.; Haddican, M. 2013: Efficacy and safety of tretinoin 0.025%/clindamycin phosphate 1.2% gel in combination with benzoyl peroxide 6% cleansing cloths for the treatment of facial acne vulgaris Journal of Drugs in Dermatology: Jdd 12(3): 277-282
Webster, G.; Rich, P.; Gold, M.H.; Mraz, S.; Calvarese, B.; Chen, D. 2009: Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in moderate or severe acne subpopulations Journal of Drugs in Dermatology: Jdd 8(8): 736-743
Eichenfield, L.F.; Krakowski, A.C. 2012: Moderate to severe acne in adolescents with skin of color: benefits of a fixed combination clindamycin phosphate 1.2% and benzoyl peroxide 2.5% aqueous gel Journal of Drugs in Dermatology: Jdd 11(7): 818-824
Amar, L.; Kircik, L.H. 2018: Treatment of Moderate Acne Vulgaris in Fitzpatrick Skin Type V or VI: Efficacy and Tolerability of Fixed Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.75% Gel Journal of Drugs in Dermatology: Jdd 17(10): 1107-1112
Cook-Bolden, F.E. 2012: Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel Journal of Drugs in Dermatology: Jdd 11(4): 455-459
Marzo, A.; Ghirardi, P.; Croce, G. 1972: Pharmacokinetics of creatinol-o-phosphate La Clinica Terapeutica 62(5): 419-430